US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harmony Biosciences Holdings, Inc.

32.06

+0.13000.41%

Post-market: 32.060.00000.00%17:59 EDT

Volume:548.42K

Turnover:17.54M

Market Cap:1.84B

PE:12.23

High:32.46

Open:32.27

Low:31.66

Close:31.93

Loading ...

Overview Company News Filings

Press Release: Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

HRMY or ONC: Which Is the Better Value Stock Right Now?

Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now

Harmony Biosciences Holdings, Inc (HRMY): A Cheap Biotech Stock to Invest In Now

Deutsche Bank Initiates Coverage on Harmony Biosciences With Buy Rating, $55 Price Target

MT Newswires Live

Harmony Biosciences initiated with a Buy at Deutsche Bank

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally?

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi

BofA Adjusts Price Target on Harmony Biosciences to $31 From $32

MT Newswires Live

VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up

Axsome Gets FDA Nod for New Migraine Drug Symbravo, Stock Rises

HRMY vs. RGEN: Which Stock Is the Better Value Option?

FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases

SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up

Harmony Biosciences Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Harmony Biosciences Holdings: A Promising Future Driven by WAKIX Expansion and Innovative Pipeline

Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals?

Simply Wall St.

Is it a Good Idea to Invest in Beam Therapeutics Stock Now?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HRMY/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HRMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HRMY\",,,,,undefined,":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":32.06,"timestamp":1750795200000,"preClose":31.93,"halted":0,"volume":548415,"hourTrading":{"tag":"盘后","latestPrice":32.06,"preClose":32.06,"latestTime":"17:59 EDT","volume":24873,"amount":797428.38,"timestamp":1750802391111},"delay":0,"floatShares":44457597,"shares":57424319,"eps":2.621478,"marketStatus":"Post-Mkt","change":0.13,"latestTime":"06-24 19:11:40 EDT","open":32.27,"high":32.46,"low":31.66,"amount":17536391.15067,"amplitude":0.025055,"askPrice":32.44,"askSize":5,"bidPrice":31.66,"bidSize":5,"shortable":3,"etf":0,"ttmEps":2.621478,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750809600000},"marketStatusCode":4,"adr":0,"listingDate":1597809600000,"exchange":"NASDAQ","adjPreClose":31.93,"postHourTrading":{"tag":"盘后","latestPrice":32.06,"preClose":32.06,"latestTime":"17:59 EDT","volume":24873,"amount":797428.38,"timestamp":1750802391111},"volumeRatio":0.879352,"impliedVol":0.6067,"impliedVolPercentile":0.376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HRMY\",,,,,undefined,":{"symbol":"HRMY","floatShares":44457597,"roa":"12.81%","roe":"24.71%","lyrEps":2.557648,"volumeRatio":0.879352,"shares":57424319,"dividePrice":0,"high":32.46,"amplitude":0.025055,"preClose":31.93,"low":31.66,"week52Low":26.47,"pbRate":"2.56","psRate":"2.47","week52High":41.61,"institutionHeld":0,"latestPrice":32.06,"eps":2.621478,"divideRate":0,"volume":548415,"delay":0,"ttmEps":2.621478,"open":32.27,"prevYearClose":34.41,"prevWeekClose":31.89,"prevMonthClose":34.5,"prevQuarterClose":33.19,"fiveDayClose":32.9,"twentyDayClose":34.17,"sixtyDayClose":33.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HRMY\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512529811","title":"Press Release: Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512529811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512529811?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:05","pubTimestamp":1739883900,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, Inc.  today announced that it will report fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on February 25, 2025, at 8:30 a.m. ET to discuss the results.To participate in the call, please dial 800-445-7795  or 785-424-1699 , and reference passcode HRMYQ424. It is recommended that you dial in at least 10 minutes prior to the call.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"gpt_icon":0},{"id":"2512992203","title":"HRMY or ONC: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512992203","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512992203?lang=en_us&edition=fundamental","pubTime":"2025-02-18 00:40","pubTimestamp":1739810413,"startTime":"0","endTime":"0","summary":"Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc.  and BeiGene, Ltd. . But which of these two stocks is more attractive to value investors?We'll need to take a closer look to find out.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.Harmony Biosciences Holdings, Inc. has a Zacks Rank of #1 , while BeiGene, Ltd. has a Zacks Rank of #3  right now. Investors should feel comfortable knowing that HRMY likely has seen a stronger improvement to its earnings outlook than ONC has recently. But this is only part of the picture for value investors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hrmy-onc-better-value-stock-164013176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HRMY","BK4007","ONC"],"gpt_icon":0},{"id":"2511760695","title":"Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2511760695","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511760695?lang=en_us&edition=fundamental","pubTime":"2025-02-14 01:45","pubTimestamp":1739468704,"startTime":"0","endTime":"0","summary":"Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score , which looks beyond the traditional growth attributes to analyze a company's real growth prospects.Harmony Biosciences Holdings, Inc.  is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.Studies have shown that stocks with the best growth features consistently outperform the market. And returns are even better for stocks that possess the combination of a Growth Score of A or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-growth-investors-buy-harmony-174504000.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","ISBC","HRMY","BK4007"],"gpt_icon":0},{"id":"2510521320","title":"Harmony Biosciences Holdings, Inc (HRMY): A Cheap Biotech Stock to Invest In Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2510521320","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510521320?lang=en_us&edition=fundamental","pubTime":"2025-02-12 19:17","pubTimestamp":1739359028,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now.In this article, we are going to take a look at where Harmony Biosciences Holdings, Inc  stands against the other cheap biotech stocks.Biotech Stocks Face Uncertainty Despite Interest Rate Cuts. Biotechnology stocks are among the most volatile in the market due to their high risk. The outcomes of FDA clinical trials and the effectiveness of their therapies in the real world might cause significant fluctuations in their pricing. The introduction of COVID-19 vaccinations in 2020 caused the biotech industry to soar to prominence. As Big Pharma started investing in acquisitions, investor interest increased in late 2023 and early 2024. But the momentum faded, and for months, biotech stocks did not move. Few M&A transactions and initial public offerings  broke the otherwise quiet period in the second quarter, which saw a steep fall in biopharma deal activity. This slowdown followed a thriving first quarter in which p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/harmony-biosciences-holdings-inc-hrmy-111708917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HRMY","BK4159","CAGR","BK4007","USAW.SI","NVIW.SI","TSYW.SI","NQmain","SQQQ","TQQQ","PSQ","QID",".IXIC","USJW.SI","QLD","MNQmain"],"gpt_icon":1},{"id":"2510800064","title":"Deutsche Bank Initiates Coverage on Harmony Biosciences With Buy Rating, $55 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800064","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800064?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:18","pubTimestamp":1739276312,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings (HRMY) has an average rating of Buy and mean price target of $54.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DB","HRMY"],"gpt_icon":0},{"id":"2510806008","title":"Harmony Biosciences initiated with a Buy at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2510806008","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510806008?lang=en_us&edition=fundamental","pubTime":"2025-02-11 18:25","pubTimestamp":1739269532,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst David Hoang initiated coverage of Harmony Biosciences (HRMY) with a Buy rating and $55 price target Published first on TheFly...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-initiated-with-a-buy-at-deutsche-bank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/harmony-biosciences-initiated-with-a-buy-at-deutsche-bank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4552","BK4585","BK4007","BK4588","BK4566","DB","BK4118"],"gpt_icon":0},{"id":"2509747047","title":"Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2509747047","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509747047?lang=en_us&edition=fundamental","pubTime":"2025-02-07 21:53","pubTimestamp":1738936380,"startTime":"0","endTime":"0","summary":"Insmed Incorporated INSM announced that the FDA has accepted its new drug application  seeking approval of its reversible inhibitor of dipeptidyl peptidase 1 , brensocatib, for treating patients with non-cystic fibrosis bronchiectasis.With the FDA granting a priority review to the NDA, a decision from the regulatory body is expected on Aug. 12, 2025.If approved, brensocatib will become the first and only approved treatment for bronchiectasis, a chronic lung disease with no approved treatments. It would also become the first DPP1 inhibitor to be approved for the treatment of neutrophil-mediated diseases.Last month, the company outlined key pipeline goals for 2025. At the time, management stated that upon approval, it expects to launch brensocatib in the United States in the third quarter of 2025.In the past year, shares of Insmed have skyrocketed 182.7% against the industry’s decline of 6.5%.INSM's Brensocatib NDA Based on Data from ASPEN Study. The latest NDA was based on data from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insmeds-nda-lung-disease-drug-135300938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","BK4585","BK4505","BK4196","HRMY","BK4007","BK4139","LU0053671581.USD","CSTL","LU0889565916.HKD","LU0109394709.USD","BK4588","ARGX","INSM"],"gpt_icon":0},{"id":"2509209101","title":"RZLT Shares Rise 30.8% in 6 Months: What's Driving the Rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=2509209101","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509209101?lang=en_us&edition=fundamental","pubTime":"2025-02-06 23:35","pubTimestamp":1738856100,"startTime":"0","endTime":"0","summary":"Shares of Rezolute RZLT have rallied 30.8% in the past six months against the industry’s decline of 4.1%, driven by investor enthusiasm about the company’s encouraging progress with the development activities for its lead pipeline candidate, ersodetug .Rezolute is a late-stage clinical biotech focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism .The company is evaluating ersodetug in the phase III sunRIZE study for treating patients with congenital HI, an ultra-rare pediatric genetic disorder.An independent Data Monitoring Committee  reviewed the OLA of the sunRIZE study, which evaluated ersodetug in eight infants aged between three months to one year for treating congenital HI. Per the DMC review, treatment with ersodetug was generally safe and well-tolerated in the given patient population. The DMC also approved the enrollment of subsequent infants into the double-blind portion of the study.Some better-ranked stocks in the biotech sector are Harm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rzlt-shares-rise-30-8-153500425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2125154778.USD","RZLT","IE00B7SZLL34.SGD","LU0029874061.USD","BMRN","BK4196","BK4007","BK4161","LU0128526141.USD","CSTL","BK4139","BK4566","IE00B19Z3B42.SGD","LU2125154935.USD","IE0002270589.USD","IE00B19Z3581.USD","LU2360032135.SGD","HI","HRMY"],"gpt_icon":0},{"id":"2509823640","title":"Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2509823640","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509823640?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:40","pubTimestamp":1738766417,"startTime":"0","endTime":"0","summary":"Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the \"Value\" category. Stocks with high Zacks Ranks and \"A\" grades for Value will be some of the highest-quality value stocks on the market today.Harmony Biosciences  is a stock many investors are watching right now. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/investors-undervaluing-harmony-biosciences-hrmy-144017802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HRMY","ISBC","BK4007","BK4211"],"gpt_icon":0},{"id":"2509644462","title":"CHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's Imfinzi","url":"https://stock-news.laohu8.com/highlight/detail?id=2509644462","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509644462?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:07","pubTimestamp":1738685220,"startTime":"0","endTime":"0","summary":"Johnson & Johnson JNJ announced that the European Medicines Agency’s  Committee for Medicinal Products for Human Use  rendered a positive opinion for the expanded use of the subcutaneous  formulation of Rybrevant  in advanced EGFR-mutated non-small cell lung cancer .The CHMP recommendation is for SC Rybrevant in combination with Lazcluze  for the first-line treatment of patients with advanced NSCLC with EGFR exon 19 deletion  or L858R mutation. The CHMP also recommended marketing authorization for the SC formulation of Rybrevant as a monotherapy for treating adult patients with advanced NSCLC with activating EGFR exon 20 insertion mutations after failure of platinum-based therapy.The European Commission had approved a combination of its intravenously administered Rybrevant plus Lazcluze for a similar use in Europe in December 2024.In the past year, shares of J&J have lost 2.5% compared with the industry’s decline of 2.6%.CHMP Nod to JNJ's Rybrevant Based on Data From PALOMA-3 Study. Im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chmp-gives-nod-expanded-j-160700577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ","BK4139","IE00BFTCPJ56.SGD","LU0912757837.SGD","IE00BGHQF631.EUR","LU2417539215.USD","CHMP","IE0002270589.USD","AZN","LU0203347892.USD","IE00BJT1NW94.SGD","IE00B7SZLL34.SGD","LU2347655156.SGD","BK4087","LU2112291526.USD","LU2505996509.AUD","IE00BSNM7G36.USD","PK","BK4585","SG9999002224.SGD","LU0466842654.USD","LU0889566641.SGD","LU0345769128.USD","BK4581","IE00BJJMRZ35.SGD","LU1162221912.USD","LU0795875169.SGD","LU1585245621.USD","LU0889565916.HKD","LU0320765646.SGD","LU1023059063.AUD","LU1674673691.USD","LU0234572021.USD","BK4213","IE00B2B36J28.USD","BK4181","LU1059921491.USD","CRT","LU1061106388.HKD","BK4534","HRMY","IE0034235303.USD","IE0009355771.USD","LU1066053197.SGD","BK4533","LU1244550577.SGD","LU1914381329.SGD","LU2089984988.USD","BMRN","LU1261432733.SGD"],"gpt_icon":0},{"id":"2508142431","title":"BofA Adjusts Price Target on Harmony Biosciences to $31 From $32","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142431","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508142431?lang=en_us&edition=fundamental","pubTime":"2025-02-03 23:34","pubTimestamp":1738596853,"startTime":"0","endTime":"0","summary":"Harmony Biosciences (HRMY) has an average rating of buy and mean price target of $54.12, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY"],"gpt_icon":0},{"id":"2508998150","title":"VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2508998150","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508998150?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:56","pubTimestamp":1738338960,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral, non-opioid, highly selective NaV1.8 pain signal inhibitor, suzetrigine, for the treatment of adults with moderate-to-severe acute pain. The pain drug will be marketed by the name of Journavx.Following the nod, Journavx has become the first and only non-opioid oral pain signal inhibitor and the first new class of pain medicine to be approved by the FDA in more than 20 years.Per the company, Journavx has the potential to transform the treatment paradigm of acute pain. Pain is an area with limited treatment options, mostly highly addictive opioid-based medications.Vertex believes Journavx, a non-opioid drug, is an effective and well-tolerated medicine for use in all types of moderate-to-severe acute pain.Shares of VRTX were up more than 8% in after-hours trading on Jan. 30 following the news announcement. The stock was also up in pre-market trading on Jan. 31.Besides acute pain, suzetrigine is also bein","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vrtx-gets-fda-nod-non-155600022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0417517546.SGD","LU2462157665.USD","IE00B19Z9Z06.USD","IE00B19Z3B42.SGD","LU0061475181.USD","LU0289739699.SGD","BK4566","LU0320765992.SGD","LU1069344957.HKD","LU1093756168.USD","BK4196","IE00B4R5TH58.HKD","LU2362541513.USD","LU2362541273.HKD","IE00B894F039.SGD","LU1815336091.USD","IE00B19Z9P08.USD","VRTX","LU1430594728.SGD","LU2456880835.USD","BK4139","IE00B7SZLL34.SGD","BK4023","BK4567","BK4007","VERX","LU0889565916.HKD","LU0234570918.USD","LU1559883803.SGD","LU0757428866.USD","LU1035775433.USD","BMRN","LU1585245621.USD","HRMY","IE00BFTCPJ56.SGD","LU0823416689.USD","LU2237438978.USD","LU2362540622.SGD","LU0109394709.USD","LU1093756325.SGD","LU2236285917.USD","BK4585","LU0058720904.USD","BK4532","BK4533","LU0256863811.USD","CSTL","IE0009355771.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2508998698","title":"Axsome Gets FDA Nod for New Migraine Drug Symbravo, Stock Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2508998698","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508998698?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:51","pubTimestamp":1738338660,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo  for the acute treatment of migraine with or without aura in adults.Per the company, Symbravo, a novel, oral medicine, offers a multi-mechanistic approach to treating migraine. It targets multiple pathways underlying a migraine attack.AXSM expects to launch Symbravo in the United States in about four months.Shares of AXSM were up 3.5% on Jan. 30 following the news announcement.The stock has rallied 20.8% in the past year against the industry’s decline of 10.2%.Axsome’s second marketed drug, Sunosi, is approved for treating narcolepsy. The company acquired U.S. rights to Sunosi from Jazz Pharmaceuticals JAZZ in May 2022. It began selling Sunosi in the U.S. market in May 2022 and in certain international markets in November 2022.The acquisition of Sunosi from Jazz diversified Axsome’s portfolio of drugs. In the first nine months of 2024, Sunosi’s net product sales were $65.6 million, reflecting an increase of alm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-gets-fda-nod-migraine-155100511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2T93.GBP","IE00B7SZLL34.SGD","BMRN","LU0109394709.USD","BK4007","BK4532","AXSM","JAZZ","BK4585","LU0320765992.SGD","IE00BN0W2V16.EUR","BK4505","IE00BN0W2W23.USD","BK4139","BK4566","BK4533","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU0889565916.HKD","HRMY"],"gpt_icon":1},{"id":"2507679147","title":"HRMY vs. RGEN: Which Stock Is the Better Value Option?","url":"https://stock-news.laohu8.com/highlight/detail?id=2507679147","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507679147?lang=en_us&edition=fundamental","pubTime":"2025-01-31 00:40","pubTimestamp":1738255207,"startTime":"0","endTime":"0","summary":"Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc.  and Repligen . But which of these two stocks presents investors with the better value opportunity right now?There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.Harmony Biosciences Holdings, Inc. and Repligen are sporting Zacks Ranks of #1  and #3 , respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that HRMY has an improving earnings outlook. But this is only part of the picture for value investors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hrmy-vs-rgen-stock-better-164007389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0757428866.USD","LU1815336091.USD","RGEN","BK4007","BK4121","HRMY"],"gpt_icon":0},{"id":"2507487654","title":"FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2507487654","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507487654?lang=en_us&edition=fundamental","pubTime":"2025-01-30 00:34","pubTimestamp":1738168440,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational new drug  application to begin clinical studies on its investigational CRISPR-based allogenic CAR-T therapy, ALLO-329, for the treatment of various autoimmune diseases.The phase I RESOLUTION basket study will evaluate the safety and preliminary efficacy of ALLO-329 in patients with systemic lupus erythematosus, including lupus nephritis, idiopathic inflammatory myopathies and systemic sclerosis.The study, which aims to offer a key understanding of ALLO-329's potential to transform the treatment paradigm across a range of autoimmune diseases, is expected to begin in mid-2025. The company expects to have proof-of-concept from the basket study by the end of 2025.A next-generation allogeneic CAR T-cell therapy, ALLO-329, works by targeting both CD19+ B-cells and CD70+ activated T-cells. Additionally, the candidate incorporates ALLO’s proprietary Dagger technology, which is designed to reduce or eliminat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-clears-allogenes-ind-car-163400440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ALLO","BK4196","IE00B7SZLL34.SGD","BK4139","BMRN","IE00B19Z3B42.SGD","BK4566","IE0002270589.USD","CAR","HRMY","IE00B19Z3581.USD","CSTL","BK4505"],"gpt_icon":0},{"id":"2507542821","title":"SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2507542821","media":"Zacks","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507542821?lang=en_us&edition=fundamental","pubTime":"2025-01-29 00:54","pubTimestamp":1738083240,"startTime":"0","endTime":"0","summary":"Sage Therapeutics SAGE announced that its board of directors has rejected the unsolicited, non-binding proposal offer from drug giant Biogen BIIB to acquire the remaining shares of SAGE.Per Sage Therapeutics, the BIIB offer significantly undervalues the company and is not in the best interest of shareholders.SAGE’s board of directors has now started exploring strategic alternatives and evaluating other options to maximize its shareholders’ value.Shares of SAGE were up 4.8% on Jan. 27 following the news announcement.In the past year, the stock has plunged 72% compared with the industry’s decline of 12.4%.Earlier this month, Biogen made an acquisition offer to buy the remaining shares of SAGE that it does not already own for $7.22 per share. The offer price represented a premium of 30% on Sage Therapeutics’ closing price of $5.55 on Jan. 10.Biogen currently owns a 10.2% stake in SAGE, per a SEC filing by the company.Some better-ranked stocks in the biotech sector are Harmony Biosciences ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sage-rejects-biogens-offer-buy-165400180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","PPD","MCI","BK4007","BK4581","BK4139","BK4590","HRMY","LU0109394709.USD","BIIB","BK4585","BK4196","BK4144","CSTL","BK4588","BK4530","LU0234570918.USD","IE00B19Z9Z06.USD","BK4561","SAGE","BK4533","LU0889565916.HKD","IE00B894F039.SGD","ET","IE00B19Z9P08.USD","BK4121","LU0320765992.SGD"],"gpt_icon":0},{"id":"2506518376","title":"Harmony Biosciences Price Target Maintained With a $75.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2506518376","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506518376?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:02","pubTimestamp":1737979320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2025 07:02 ET (12:02 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY"],"gpt_icon":0},{"id":"2506402378","title":"Harmony Biosciences Holdings: A Promising Future Driven by WAKIX Expansion and Innovative Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2506402378","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506402378?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:16","pubTimestamp":1737976564,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Harmony Biosciences Holdings (HRMY – Research Report),...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/harmony-biosciences-holdings-a-promising-future-driven-by-wakix-expansion-and-innovative-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/harmony-biosciences-holdings-a-promising-future-driven-by-wakix-expansion-and-innovative-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HRMY"],"gpt_icon":0},{"id":"2506759468","title":"Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506759468","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506759468?lang=en_us&edition=fundamental","pubTime":"2025-01-25 20:25","pubTimestamp":1737807954,"startTime":"0","endTime":"0","summary":"Most readers would already be aware that Harmony Biosciences Holdings'  stock increased significantly by 12% over the past month. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's financial health over the long-term usually dictates market outcomes. Specifically, we decided to study Harmony Biosciences Holdings'  ROE in this article.Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.View our latest analysis for Harmony Biosciences Holdings. Harmony Biosciences Holdings' Earnings Growth And 21% ROE. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/harmony-biosciences-holdings-inc-nasdaq-122554613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ",".IXIC","SQQQ","NQmain","MNQmain","USJW.SI","LU2095319765.USD","TSYW.SI","USAW.SI","LU2210150020.SGD","PSQ","BK4112","BK4007","TQQQ","HRMY","IE00BKPKM429.USD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","QLD","NVIW.SI","QID","BK4588","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2506893707","title":"Is it a Good Idea to Invest in Beam Therapeutics Stock Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506893707","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506893707?lang=en_us&edition=fundamental","pubTime":"2025-01-24 23:40","pubTimestamp":1737733200,"startTime":"0","endTime":"0","summary":"Beam Therapeutics BEAM is developing its lead pipeline candidate, BEAM-101, a base-editing therapy, in the phase I/II BEACON study for treating sickle cell disease , an inherited blood disorder.BEAM’s pipeline of gene editing therapies is based on its proprietary base editing technology.The company believes that its innovative next-generation technology called base-editing technology can provide a superior way to modify genes and could open up entirely new applications in gene editing, targeting a wide range of severe diseases. It can also make more precise single-base changes at specific locations in genes, resulting in predictable edits in all cells, without needing to damage or make double-stranded breaks in the DNA.Beam Therapeutics currently has a Zacks Rank #2 . In the past 60 days, estimates for BEAM’s 2025 loss per share have narrowed from $4.62 to $4.32.In the past 60 days, estimates for Voyager Therapeutics’ loss per share have narrowed from $1.72 to $1.58 for 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/good-idea-invest-beam-therapeutics-154000464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","CSTL","VYGR","BEAM","BK4556","BK4139","BK4585","SCD","BK4505","HRMY","BK4007","BK4535","BK4588","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":139,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HRMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"HRMY","fiscalQuarterEnding":"2025/03","expectedEps":0.59,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":0.78},{"market":"US","date":"2025-02-25","symbol":"HRMY","fiscalQuarterEnding":"2024/12","expectedEps":0.74,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"pre","actualEps":0.85},{"market":"US","date":"2025-01-13","symbol":"HRMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-10-29","symbol":"HRMY","fiscalQuarterEnding":"2024/09","expectedEps":0.64,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"pre","actualEps":0.79},{"market":"US","date":"2024-08-06","symbol":"HRMY","fiscalQuarterEnding":"2024/06","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HRMY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HRMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.7778,"hold":0,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7778,"analysts":9,"updateTime":1739419200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HRMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HRMY","date":"2025-06-23","current":11.991052,"percent":0.286344,"low":-51.434337,"twenty":10.590425,"median":15.608321,"eighty":78.003851,"high":224.320286,"avg":40.396451,"sd":63.943538,"marketCap":1831261532},"quantilePoints":[{"date":"2020-08-21","current":-2.608283,"twenty":-3.097399,"median":-2.794436,"eighty":-2.61408,"marketCap":279052416},{"date":"2020-08-28","current":-2.550322,"twenty":-2.794436,"median":-2.584374,"eighty":-2.463379,"marketCap":272851251},{"date":"2020-09-04","current":-2.998801,"twenty":-2.940839,"median":-2.615529,"eighty":-2.532933,"marketCap":320832763},{"date":"2020-09-11","current":-3.198045,"twenty":-3.089367,"median":-2.794436,"eighty":-2.556408,"marketCap":342149267},{"date":"2020-09-18","current":-2.434398,"twenty":-3.028072,"median":-2.718749,"eighty":-2.530615,"marketCap":260448921},{"date":"2020-09-25","current":-2.449613,"twenty":-2.99402,"median":-2.608283,"eighty":-2.443527,"marketCap":262076727},{"date":"2020-10-02","current":-19.552182,"twenty":-2.99402,"median":-2.572782,"eighty":-2.425994,"marketCap":2091829329},{"date":"2020-10-09","current":-20.39736,"twenty":-3.20529,"median":-2.615529,"eighty":-2.443527,"marketCap":2182252393},{"date":"2020-10-16","current":-23.534042,"twenty":-19.006983,"median":-2.794436,"eighty":-2.453526,"marketCap":2517836581},{"date":"2020-10-23","current":-24.141142,"twenty":-20.193803,"median":-2.885051,"eighty":-2.460481,"marketCap":2582788359},{"date":"2020-10-30","current":-23.153117,"twenty":-22.441262,"median":-2.994816,"eighty":-2.463379,"marketCap":2477082524},{"date":"2020-11-06","current":-27.170689,"twenty":-23.169783,"median":-3.11545,"eighty":-2.485984,"marketCap":2906910469},{"date":"2020-11-13","current":-34.397326,"twenty":-23.548327,"median":-3.762706,"eighty":-2.518877,"marketCap":2517058716},{"date":"2020-11-20","current":-33.94253,"twenty":-24.636345,"median":-18.921275,"eighty":-2.542497,"marketCap":2483778586},{"date":"2020-11-27","current":-36.920081,"twenty":-27.820643,"median":-19.326008,"eighty":-2.554379,"marketCap":2701663881},{"date":"2020-12-04","current":-37.122213,"twenty":-32.061363,"median":-20.227729,"eighty":-2.562783,"marketCap":2716455050},{"date":"2020-12-11","current":-32.47319,"twenty":-33.317478,"median":-22.141284,"eighty":-2.571477,"marketCap":2376258166},{"date":"2020-12-18","current":-27.723102,"twenty":-33.221076,"median":-22.575777,"eighty":-2.590894,"marketCap":2028665698},{"date":"2020-12-24","current":-28.360593,"twenty":-33.107572,"median":-23.051934,"eighty":-2.609732,"marketCap":2075314769},{"date":"2020-12-31","current":-28.104042,"twenty":-33.064036,"median":-23.200733,"eighty":-2.615529,"marketCap":2056541362},{"date":"2021-01-08","current":-28.60937,"twenty":-32.47319,"median":-23.534042,"eighty":-2.643061,"marketCap":2093519284},{"date":"2021-01-15","current":-30.179776,"twenty":-31.757956,"median":-23.941751,"eighty":-2.794436,"marketCap":2208435289},{"date":"2021-01-22","current":-28.438336,"twenty":-31.191988,"median":-24.641106,"eighty":-2.794436,"marketCap":2081003680},{"date":"2021-01-29","current":-27.878588,"twenty":-30.776841,"median":-27.170689,"eighty":-2.796214,"marketCap":2040043520},{"date":"2021-02-05","current":-31.136013,"twenty":-30.776841,"median":-27.548181,"eighty":-2.867373,"marketCap":2278408895},{"date":"2021-02-12","current":-28.834825,"twenty":-30.944766,"median":-27.723102,"eighty":-2.918089,"marketCap":2110017126},{"date":"2021-02-19","current":-29.161345,"twenty":-30.862358,"median":-27.761973,"eighty":-2.965039,"marketCap":2133910553},{"date":"2021-02-26","current":-27.57539,"twenty":-30.755073,"median":-27.878588,"eighty":-2.995613,"marketCap":2017856767},{"date":"2021-03-05","current":-25.188685,"twenty":-30.617783,"median":-27.761973,"eighty":-3.042707,"marketCap":1843207196},{"date":"2021-03-12","current":-23.727119,"twenty":-30.354129,"median":-27.62981,"eighty":-3.098061,"marketCap":1736255667},{"date":"2021-03-19","current":-24.380159,"twenty":-30.195324,"median":-27.552068,"eighty":-3.165007,"marketCap":1784042520},{"date":"2021-03-26","current":-42.441027,"twenty":-30.354129,"median":-27.548181,"eighty":-3.208913,"marketCap":1567941315},{"date":"2021-04-01","current":-49.417002,"twenty":-30.881017,"median":-27.594826,"eighty":-3.653396,"marketCap":1825661712},{"date":"2021-04-09","current":-43.611762,"twenty":-31.60869,"median":-27.723102,"eighty":-10.142158,"marketCap":1611192937},{"date":"2021-04-16","current":-43.349968,"twenty":-33.221076,"median":-27.878588,"eighty":-18.903419,"marketCap":1601521228},{"date":"2021-04-23","current":-43.334569,"twenty":-33.693753,"median":-28.018525,"eighty":-19.006983,"marketCap":1600952304},{"date":"2021-04-30","current":-45.120926,"twenty":-33.956524,"median":-28.123477,"eighty":-19.21173,"marketCap":1666947495},{"date":"2021-05-07","current":-42.687784,"twenty":-34.318028,"median":-28.166236,"eighty":-19.416478,"marketCap":1577057494},{"date":"2021-05-14","current":175.060652,"twenty":-34.318028,"median":-28.135139,"eighty":-18.903419,"marketCap":1586399629},{"date":"2021-05-21","current":201.621146,"twenty":-34.183533,"median":-28.104042,"eighty":-3.148488,"marketCap":1827090821},{"date":"2021-05-28","current":200.679284,"twenty":-34.16021,"median":-27.940782,"eighty":-2.952142,"marketCap":1818555672},{"date":"2021-06-04","current":208.402548,"twenty":-34.121339,"median":-27.820281,"eighty":-2.794881,"marketCap":1888543891},{"date":"2021-06-11","current":200.867656,"twenty":-33.961188,"median":-27.645359,"eighty":-2.609732,"marketCap":1820262702},{"date":"2021-06-18","current":196.597884,"twenty":-33.925427,"median":-27.563729,"eighty":-2.552351,"marketCap":1781570028},{"date":"2021-06-25","current":185.735082,"twenty":-33.847684,"median":-27.41213,"eighty":-2.463379,"marketCap":1683131313},{"date":"2021-07-02","current":186.865316,"twenty":-33.796373,"median":-27.042852,"eighty":-2.417589,"marketCap":1693373492},{"date":"2021-07-09","current":182.595544,"twenty":-33.740399,"median":-26.207116,"eighty":-2.352527,"marketCap":1654680818},{"date":"2021-07-16","current":176.128095,"twenty":-33.623784,"median":-25.67069,"eighty":163.004825,"marketCap":1596072797},{"date":"2021-07-23","current":184.793221,"twenty":-33.367233,"median":-24.959343,"eighty":175.060652,"marketCap":1674596165},{"date":"2021-07-30","current":164.26064,"twenty":-33.336136,"median":-24.617299,"eighty":173.867627,"marketCap":1488529924},{"date":"2021-08-06","current":169.15832,"twenty":-33.28949,"median":-24.1246,"eighty":170.602508,"marketCap":1532912697},{"date":"2021-08-13","current":78.980541,"twenty":-33.118456,"median":-23.921476,"eighty":170.351345,"marketCap":1832822439},{"date":"2021-08-20","current":81.28977,"twenty":-33.064036,"median":-23.648436,"eighty":169.15832,"marketCap":1886410404},{"date":"2021-08-27","current":86.645216,"twenty":-32.47319,"median":-23.447245,"eighty":168.090877,"marketCap":2010688877},{"date":"2021-09-03","current":88.807047,"twenty":-31.757956,"median":-23.200733,"eighty":167.965296,"marketCap":2060856335},{"date":"2021-09-10","current":89.077276,"twenty":-31.459423,"median":-23.051934,"eighty":167.814598,"marketCap":2067127267},{"date":"2021-09-17","current":90.379288,"twenty":-31.185768,"median":-22.617441,"eighty":167.676458,"marketCap":2097341758},{"date":"2021-09-24","current":92.467421,"twenty":-31.067599,"median":-22.365217,"eighty":167.349946,"marketCap":2145798961},{"date":"2021-10-01","current":94.211625,"twenty":-30.944766,"median":-22.141284,"eighty":165.918317,"marketCap":2186274977},{"date":"2021-10-08","current":88.807047,"twenty":-30.8437,"median":-20.227729,"eighty":164.825757,"marketCap":2060856335},{"date":"2021-10-15","current":96.791083,"twenty":-30.73175,"median":-19.326008,"eighty":164.335989,"marketCap":2246133875},{"date":"2021-10-22","current":100.304059,"twenty":-30.587568,"median":-18.906395,"eighty":163.959245,"marketCap":2327655993},{"date":"2021-10-29","current":101.8763,"twenty":-30.286388,"median":-3.216158,"eighty":163.180639,"marketCap":2364141416},{"date":"2021-11-05","current":103.080047,"twenty":-30.18755,"median":-3.093714,"eighty":161.598312,"marketCap":2392075569},{"date":"2021-11-12","current":213.001602,"twenty":-30.049168,"median":-2.990832,"eighty":164.335989,"marketCap":2486793703},{"date":"2021-11-19","current":194.120435,"twenty":-29.898347,"median":-2.840855,"eighty":167.676458,"marketCap":2266356076},{"date":"2021-11-26","current":188.060432,"twenty":-29.826824,"median":-2.794436,"eighty":168.517854,"marketCap":2195605538},{"date":"2021-12-03","current":178.194145,"twenty":-29.635576,"median":-2.615529,"eighty":171.986147,"marketCap":2080416646},{"date":"2021-12-10","current":191.015309,"twenty":-29.391464,"median":-2.572782,"eighty":176.580189,"marketCap":2230103734},{"date":"2021-12-17","current":204.637796,"twenty":-29.287288,"median":-2.550322,"eighty":178.849587,"marketCap":2389146266},{"date":"2021-12-23","current":219.862928,"twenty":-29.253081,"median":-2.501054,"eighty":182.080659,"marketCap":2566899684},{"date":"2021-12-31","current":213.552511,"twenty":-29.193997,"median":-2.459757,"eighty":183.148103,"marketCap":2493225570},{"date":"2022-01-07","current":190.113821,"twenty":-29.148906,"median":-2.434398,"eighty":184.582375,"marketCap":2219578861},{"date":"2022-01-14","current":183.703239,"twenty":-29.09399,"median":-2.369915,"eighty":184.742988,"marketCap":2144735316},{"date":"2022-01-21","current":168.978934,"twenty":-29.039074,"median":-2.331154,"eighty":184.625007,"marketCap":1972829051},{"date":"2022-01-28","current":170.130835,"twenty":-29.035401,"median":-2.243124,"eighty":184.446878,"marketCap":1986277500},{"date":"2022-02-04","current":190.865061,"twenty":-28.99964,"median":76.15542,"eighty":185.043087,"marketCap":2228349589},{"date":"2022-02-11","current":185.105554,"twenty":-28.872141,"median":77.580264,"eighty":185.697408,"marketCap":2161107342},{"date":"2022-02-18","current":192.417624,"twenty":-28.825496,"median":79.017391,"eighty":187.606247,"marketCap":2246475759},{"date":"2022-02-25","current":189.963573,"twenty":-28.788179,"median":80.958125,"eighty":188.010349,"marketCap":2217824715},{"date":"2022-03-04","current":68.474584,"twenty":-28.764856,"median":78.980541,"eighty":187.618805,"marketCap":2369015195},{"date":"2022-03-11","current":74.634574,"twenty":-28.757082,"median":77.82693,"eighty":187.556014,"marketCap":2582132367},{"date":"2022-03-18","current":83.670361,"twenty":-28.725985,"median":77.973324,"eighty":187.209026,"marketCap":2894743467},{"date":"2022-03-25","current":87.005604,"twenty":-28.671565,"median":79.017391,"eighty":187.158943,"marketCap":3010132876},{"date":"2022-04-01","current":85.048701,"twenty":-28.648242,"median":81.202961,"eighty":186.865316,"marketCap":2942429907},{"date":"2022-04-08","current":84.952464,"twenty":-28.60937,"median":82.086768,"eighty":185.735082,"marketCap":2939100413},{"date":"2022-04-14","current":87.938341,"twenty":-28.472543,"median":83.020285,"eighty":185.584384,"marketCap":3042402798},{"date":"2022-04-22","current":86.965799,"twenty":-28.43367,"median":83.840526,"eighty":185.394116,"marketCap":3008755735},{"date":"2022-04-29","current":76.847941,"twenty":-28.412292,"median":83.462716,"eighty":185.155637,"marketCap":2658708227},{"date":"2022-05-06","current":42.70738,"twenty":-28.369922,"median":81.388035,"eighty":185.105554,"marketCap":2079678590},{"date":"2022-05-13","current":46.054126,"twenty":-28.354374,"median":80.914721,"eighty":184.855688,"marketCap":2242651699},{"date":"2022-05-20","current":50.116298,"twenty":-28.27372,"median":80.072688,"eighty":184.692755,"marketCap":2440463263},{"date":"2022-05-27","current":52.917379,"twenty":-28.227314,"median":78.86119,"eighty":184.497111,"marketCap":2576864669},{"date":"2022-06-03","current":54.190597,"twenty":-28.197333,"median":78.1681,"eighty":184.431677,"marketCap":2638865309},{"date":"2022-06-10","current":55.306179,"twenty":-28.172456,"median":77.680536,"eighty":184.11508,"marketCap":2693189679},{"date":"2022-06-17","current":53.329659,"twenty":-28.152242,"median":77.432866,"eighty":183.787603,"marketCap":2596941067},{"date":"2022-06-24","current":62.654467,"twenty":-28.136694,"median":76.899128,"eighty":183.611789,"marketCap":3051021940},{"date":"2022-07-01","current":63.054622,"twenty":-28.124255,"median":74.902541,"eighty":183.225503,"marketCap":3070507856},{"date":"2022-07-08","current":66.389241,"twenty":-28.11648,"median":74.566508,"eighty":182.813134,"marketCap":3232890483},{"date":"2022-07-15","current":65.055393,"twenty":-28.086939,"median":72.932919,"eighty":182.645777,"marketCap":3167937432},{"date":"2022-07-22","current":61.866285,"twenty":-28.015415,"median":69.019114,"eighty":182.556653,"marketCap":3012640592},{"date":"2022-07-29","current":61.514634,"twenty":-27.978098,"median":68.083203,"eighty":182.352074,"marketCap":2995516606},{"date":"2022-08-05","current":53.449894,"twenty":-27.878588,"median":66.595381,"eighty":182.118334,"marketCap":3105973342},{"date":"2022-08-12","current":53.093561,"twenty":-27.855265,"median":66.092157,"eighty":181.904079,"marketCap":3085266853},{"date":"2022-08-19","current":47.931829,"twenty":-27.754199,"median":65.055393,"eighty":181.41947,"marketCap":2785318570},{"date":"2022-08-26","current":48.461237,"twenty":-27.707553,"median":64.036819,"eighty":180.49049,"marketCap":2816082497},{"date":"2022-09-02","current":45.162615,"twenty":-27.63914,"median":63.770049,"eighty":180.335076,"marketCap":2624399570},{"date":"2022-09-09","current":47.860562,"twenty":-27.614262,"median":63.200132,"eighty":179.83275,"marketCap":2781177272},{"date":"2022-09-16","current":44.633207,"twenty":-27.57539,"median":62.430138,"eighty":179.59646,"marketCap":2593635644},{"date":"2022-09-23","current":43.238419,"twenty":-27.552068,"median":61.866285,"eighty":178.194145,"marketCap":2512584530},{"date":"2022-09-30","current":45.091349,"twenty":-27.544293,"median":61.441879,"eighty":178.194145,"marketCap":2620258273},{"date":"2022-10-07","current":48.16599,"twenty":-27.41213,"median":61.211487,"eighty":178.043897,"marketCap":2798925692},{"date":"2022-10-14","current":51.994021,"twenty":-27.170689,"median":59.416855,"eighty":177.258329,"marketCap":3021372544},{"date":"2022-10-21","current":51.077737,"twenty":-27.132256,"median":56.48239,"eighty":176.240921,"marketCap":2968127287},{"date":"2022-10-28","current":53.327723,"twenty":-26.953448,"median":55.912474,"eighty":176.128095,"marketCap":3098873974},{"date":"2022-11-04","current":22.424172,"twenty":-26.277085,"median":55.172794,"eighty":175.84026,"marketCap":3490838052},{"date":"2022-11-11","current":21.673524,"twenty":-26.137148,"median":54.154219,"eighty":175.75135,"marketCap":3373982471},{"date":"2022-11-18","current":21.723059,"twenty":-25.670795,"median":53.996583,"eighty":175.439598,"marketCap":3381693753},{"date":"2022-11-25","current":22.134582,"twenty":-25.670711,"median":53.449894,"eighty":175.399532,"marketCap":3445756711},{"date":"2022-12-02","current":23.045266,"twenty":-25.552521,"median":53.328691,"eighty":175.126425,"marketCap":3587525665},{"date":"2022-12-09","current":22.492759,"twenty":-25.255544,"median":53.266637,"eighty":174.106232,"marketCap":3501515212},{"date":"2022-12-16","current":21.216276,"twenty":-24.821739,"median":52.929113,"eighty":171.358987,"marketCap":3302801406},{"date":"2022-12-23","current":21.604937,"twenty":-24.677932,"median":52.635419,"eighty":170.691761,"marketCap":3363305311},{"date":"2022-12-30","current":20.995274,"twenty":-24.636345,"median":52.472525,"eighty":170.634202,"marketCap":3268397225},{"date":"2023-01-06","current":20.446577,"twenty":-24.522443,"median":52.370715,"eighty":170.502043,"marketCap":3182979947},{"date":"2023-01-13","current":18.068891,"twenty":-24.284552,"median":51.976727,"eighty":170.263141,"marketCap":2812838410},{"date":"2023-01-20","current":18.861453,"twenty":-24.134525,"median":51.858902,"eighty":169.936332,"marketCap":2936218923},{"date":"2023-01-27","current":18.507086,"twenty":-24.097175,"median":51.688593,"eighty":169.122443,"marketCap":2881053597},{"date":"2023-02-03","current":18.800486,"twenty":-24.027206,"median":51.304437,"eighty":168.801323,"marketCap":2926728114},{"date":"2023-02-10","current":17.96982,"twenty":-23.885653,"median":51.016651,"eighty":168.065761,"marketCap":2797415846},{"date":"2023-02-17","current":18.773814,"twenty":-23.739313,"median":50.338665,"eighty":167.927621,"marketCap":2922575885},{"date":"2023-02-24","current":14.893027,"twenty":-23.727119,"median":49.930166,"eighty":167.776923,"marketCap":2702607736},{"date":"2023-03-03","current":14.206364,"twenty":-23.569754,"median":49.182605,"eighty":167.651342,"marketCap":2578000408},{"date":"2023-03-10","current":13.555841,"twenty":-23.534042,"median":48.751394,"eighty":167.274597,"marketCap":2459951361},{"date":"2023-03-17","current":13.772682,"twenty":-23.447245,"median":48.49178,"eighty":166.024056,"marketCap":2499301043},{"date":"2023-03-24","current":13.697116,"twenty":-23.295964,"median":48.332425,"eighty":165.973973,"marketCap":2485588275},{"date":"2023-03-31","current":10.727053,"twenty":-23.206685,"median":48.16599,"eighty":165.579247,"marketCap":1946616867},{"date":"2023-04-06","current":10.191522,"twenty":-23.197162,"median":48.084543,"eighty":164.825757,"marketCap":1849435075},{"date":"2023-04-14","current":10.444503,"twenty":-23.16145,"median":47.799476,"eighty":164.335989,"marketCap":1895343038},{"date":"2023-04-21","current":10.464105,"twenty":-22.991223,"median":47.483868,"eighty":163.959245,"marketCap":1898900213},{"date":"2023-04-27","current":10.464105,"twenty":-22.822828,"median":47.420421,"eighty":163.532268,"marketCap":1898900213},{"date":"2023-05-05","current":11.249323,"twenty":-22.625543,"median":47.096952,"eighty":162.301569,"marketCap":2131386669},{"date":"2023-05-12","current":11.489815,"twenty":-22.58411,"median":46.560864,"eighty":139.011812,"marketCap":2176952179},{"date":"2023-05-19","current":11.353747,"twenty":-22.472213,"median":46.20107,"eighty":105.580893,"marketCap":2151171693},{"date":"2023-05-26","current":11.388555,"twenty":-22.368046,"median":46.066513,"eighty":105.119047,"marketCap":2157766701},{"date":"2023-05-31","current":11.100597,"twenty":-22.356729,"median":45.903617,"eighty":104.775119,"marketCap":2103207999},{"date":"2023-06-09","current":11.388555,"twenty":-22.344851,"median":45.290195,"eighty":104.445931,"marketCap":2157766701},{"date":"2023-06-16","current":11.477157,"twenty":-22.262491,"median":45.126982,"eighty":103.895647,"marketCap":2174553994},{"date":"2023-06-23","current":11.679677,"twenty":-21.893683,"median":45.026616,"eighty":103.119353,"marketCap":2212924950},{"date":"2023-06-30","current":11.179707,"twenty":-21.150878,"median":44.714654,"eighty":103.089873,"marketCap":2118196653},{"date":"2023-07-07","current":10.755682,"twenty":-20.70091,"median":44.66884,"eighty":103.021088,"marketCap":2037857465},{"date":"2023-07-10","current":10.578477,"twenty":-20.599727,"median":44.633207,"eighty":102.991608,"marketCap":2004282879},{"date":"2023-07-18","current":11.530951,"twenty":-20.498543,"median":44.531397,"eighty":102.962129,"marketCap":2184746279},{"date":"2023-07-27","current":11.233501,"twenty":-20.329508,"median":44.383774,"eighty":102.912996,"marketCap":2128388939},{"date":"2023-08-02","current":10.184955,"twenty":-20.193803,"median":44.276875,"eighty":102.87369,"marketCap":2039404928},{"date":"2023-08-11","current":9.606639,"twenty":-19.855732,"median":43.599842,"eighty":102.726292,"marketCap":1923604648},{"date":"2023-08-17","current":9.687544,"twenty":-19.506947,"median":43.330047,"eighty":102.426584,"marketCap":1939804687},{"date":"2023-08-25","current":9.5557,"twenty":-19.287915,"median":42.70738,"eighty":101.827167,"marketCap":1913404624},{"date":"2023-09-01","current":10.862155,"twenty":-19.092691,"median":41.688806,"eighty":101.493066,"marketCap":2175005256},{"date":"2023-09-08","current":11.386535,"twenty":-18.964129,"median":40.670231,"eighty":101.080353,"marketCap":2280005510},{"date":"2023-09-15","current":11.395524,"twenty":-18.903419,"median":23.045266,"eighty":100.559548,"marketCap":2281805514},{"date":"2023-10-13","current":9.068775,"twenty":-18.891515,"median":22.873798,"eighty":100.304059,"marketCap":1815904388},{"date":"2023-11-10","current":9.056496,"twenty":-7.225705,"median":22.862367,"eighty":100.146835,"marketCap":1365312014},{"date":"2023-11-17","current":10.039462,"twenty":-3.653396,"median":22.801401,"eighty":100.004351,"marketCap":1513499032},{"date":"2023-11-24","current":11.278853,"twenty":-3.208913,"median":22.729003,"eighty":98.677772,"marketCap":1700343534},{"date":"2023-12-01","current":11.290509,"twenty":-3.165007,"median":22.536578,"eighty":96.702645,"marketCap":1702100692},{"date":"2023-12-08","current":12.063672,"twenty":-3.098061,"median":22.370826,"eighty":95.882131,"marketCap":1818658861},{"date":"2023-12-15","current":13.124343,"twenty":-3.042707,"median":22.332722,"eighty":94.781562,"marketCap":1978560268},{"date":"2023-12-22","current":12.545442,"twenty":-2.995613,"median":22.134582,"eighty":94.648905,"marketCap":1891288071},{"date":"2023-12-29","current":12.949507,"twenty":-2.990832,"median":22.069805,"eighty":94.604686,"marketCap":1952202893},{"date":"2024-01-05","current":12.409458,"twenty":-2.952142,"median":21.909768,"eighty":94.501508,"marketCap":1870787891},{"date":"2024-01-12","current":12.188,"twenty":-2.90157,"median":21.820224,"eighty":94.300064,"marketCap":1837401883},{"date":"2024-01-19","current":12.401688,"twenty":-2.849694,"median":21.776404,"eighty":94.191972,"marketCap":1869616452},{"date":"2024-01-26","current":12.059787,"twenty":-2.79577,"median":21.723059,"eighty":93.995442,"marketCap":1818073141},{"date":"2024-02-02","current":12.156918,"twenty":-2.794436,"median":21.496341,"eighty":93.73504,"marketCap":1832716127},{"date":"2024-02-09","current":13.093261,"twenty":-2.733886,"median":21.376313,"eighty":93.602382,"marketCap":1973874512},{"date":"2024-02-16","current":13.621653,"twenty":-2.632048,"median":21.208655,"eighty":93.415679,"marketCap":2053532356},{"date":"2024-02-23","current":13.856003,"twenty":-2.61408,"median":21.071482,"eighty":93.3125,"marketCap":1785387597},{"date":"2024-03-01","current":14.142375,"twenty":-2.602487,"median":20.995274,"eighty":92.939093,"marketCap":1822287500},{"date":"2024-03-08","current":13.675369,"twenty":-2.576694,"median":20.518974,"eighty":92.781869,"marketCap":1762112274},{"date":"2024-03-15","current":13.816352,"twenty":-2.565102,"median":20.179849,"eighty":92.378982,"marketCap":1780278380},{"date":"2024-03-22","current":14.781205,"twenty":-2.558436,"median":18.92623,"eighty":92.000662,"marketCap":1904602667},{"date":"2024-03-28","current":14.767988,"twenty":-2.550322,"median":18.897652,"eighty":91.902396,"marketCap":1902899595},{"date":"2024-04-05","current":13.759077,"twenty":-2.530759,"median":18.857642,"eighty":91.583035,"marketCap":1772898399},{"date":"2024-04-12","current":13.777664,"twenty":-2.501054,"median":18.73571,"eighty":91.361939,"marketCap":1775293349},{"date":"2024-04-19","current":12.794804,"twenty":-2.463379,"median":18.609967,"eighty":91.337372,"marketCap":1648648942},{"date":"2024-04-26","current":12.75073,"twenty":-2.463379,"median":18.602346,"eighty":91.140842,"marketCap":1642969821},{"date":"2024-05-03","current":13.069774,"twenty":-2.456134,"median":18.507086,"eighty":91.067143,"marketCap":1799734075},{"date":"2024-05-10","current":12.90068,"twenty":-2.449613,"median":18.297514,"eighty":90.379288,"marketCap":1776449412},{"date":"2024-05-17","current":12.088201,"twenty":-2.434398,"median":18.179392,"eighty":90.158192,"marketCap":1664569445},{"date":"2024-05-24","current":12.104698,"twenty":-2.413387,"median":18.047933,"eighty":89.298372,"marketCap":1666841120},{"date":"2024-05-31","current":11.906734,"twenty":-2.382087,"median":17.946958,"eighty":89.121495,"marketCap":1639581027},{"date":"2024-06-07","current":12.587236,"twenty":-2.367307,"median":17.154396,"eighty":88.998762,"marketCap":1733287597},{"date":"2024-06-14","current":12.273793,"twenty":-2.357743,"median":15.146008,"eighty":88.886997,"marketCap":1690125783},{"date":"2024-06-21","current":11.881988,"twenty":-2.335428,"median":14.82306,"eighty":88.818163,"marketCap":1636173515},{"date":"2024-06-28","current":12.983165,"twenty":-2.318329,"median":14.794423,"eighty":88.810752,"marketCap":1787807784},{"date":"2024-07-05","current":12.739834,"twenty":-2.282393,"median":14.767988,"eighty":88.807047,"marketCap":1754300586},{"date":"2024-07-12","current":13.742028,"twenty":-2.251528,"median":14.690611,"eighty":88.792307,"marketCap":1892304808},{"date":"2024-07-15","current":13.919372,"twenty":-2.247326,"median":14.675468,"eighty":88.787394,"marketCap":1916725308},{"date":"2024-08-02","current":13.494573,"twenty":-2.243124,"median":14.664454,"eighty":88.782481,"marketCap":1858229691},{"date":"2024-08-09","current":16.799396,"twenty":9.056496,"median":14.675468,"eighty":88.487686,"marketCap":1931812982},{"date":"2024-08-16","current":17.422145,"twenty":9.068775,"median":14.759177,"eighty":87.938341,"marketCap":2003424761},{"date":"2024-08-23","current":17.797772,"twenty":9.239102,"median":14.794423,"eighty":87.480469,"marketCap":2046619167},{"date":"2024-08-30","current":17.669268,"twenty":9.297381,"median":15.019517,"eighty":87.005604,"marketCap":2031842133},{"date":"2024-09-06","current":17.575361,"twenty":9.390627,"median":15.713966,"eighty":86.97376,"marketCap":2021043532},{"date":"2024-09-13","current":18.662701,"twenty":9.451236,"median":16.581928,"eighty":86.82725,"marketCap":2146079971},{"date":"2024-09-20","current":19.270623,"twenty":9.536672,"median":16.913072,"eighty":86.781015,"marketCap":2215986707},{"date":"2024-09-27","current":19.666019,"twenty":9.560494,"median":17.268929,"eighty":86.769521,"marketCap":2261454503},{"date":"2024-10-04","current":17.184908,"twenty":9.585664,"median":17.382606,"eighty":86.762317,"marketCap":1976144083},{"date":"2024-10-11","current":17.204677,"twenty":9.603643,"median":17.204677,"eighty":86.668383,"marketCap":1978417473},{"date":"2024-10-18","current":17.283757,"twenty":9.670052,"median":17.244217,"eighty":86.164597,"marketCap":1987511032},{"date":"2024-10-25","current":16.829051,"twenty":9.687216,"median":17.22939,"eighty":85.99443,"marketCap":1935223067},{"date":"2024-10-31","current":15.719942,"twenty":9.687544,"median":17.22939,"eighty":85.6364,"marketCap":1927657838},{"date":"2024-11-08","current":16.236188,"twenty":9.700129,"median":17.20962,"eighty":85.406048,"marketCap":1990962578},{"date":"2024-11-15","current":15.347872,"twenty":9.710317,"median":17.175023,"eighty":85.379593,"marketCap":1882032801},{"date":"2024-11-22","current":15.454842,"twenty":9.715111,"median":17.076173,"eighty":85.306485,"marketCap":1895149999},{"date":"2024-11-29","current":16.124567,"twenty":9.728295,"median":17.00945,"eighty":85.251887,"marketCap":1977275066},{"date":"2024-12-06","current":15.575765,"twenty":9.745913,"median":16.829051,"eighty":85.154756,"marketCap":1909978136},{"date":"2024-12-13","current":14.817673,"twenty":9.758618,"median":16.7528,"eighty":85.021475,"marketCap":1817017122},{"date":"2024-12-20","current":15.761799,"twenty":9.806803,"median":16.606641,"eighty":84.969367,"marketCap":1932790655},{"date":"2024-12-27","current":16.147822,"twenty":9.880515,"median":16.512734,"eighty":84.941082,"marketCap":1980126631},{"date":"2025-01-03","current":16.198981,"twenty":9.981196,"median":16.315253,"eighty":84.895552,"marketCap":1986400074},{"date":"2025-01-10","current":16.059455,"twenty":10.012781,"median":16.240839,"eighty":84.854712,"marketCap":1969290685},{"date":"2025-01-17","current":17.924454,"twenty":10.034639,"median":16.32688,"eighty":84.844502,"marketCap":2197986186},{"date":"2025-01-24","current":17.677958,"twenty":10.038929,"median":16.437248,"eighty":84.803662,"marketCap":2167759598},{"date":"2025-01-31","current":18.389541,"twenty":10.056641,"median":16.606641,"eighty":84.630085,"marketCap":2255017483},{"date":"2025-02-07","current":18.036075,"twenty":10.098782,"median":16.7528,"eighty":84.515509,"marketCap":2211673697},{"date":"2025-02-14","current":18.173276,"twenty":10.121213,"median":16.829051,"eighty":84.314822,"marketCap":2228497930},{"date":"2025-02-21","current":16.226886,"twenty":10.147498,"median":16.829051,"eighty":84.151463,"marketCap":1989821952},{"date":"2025-02-28","current":12.90831,"twenty":10.187582,"median":16.7528,"eighty":84.020901,"marketCap":1878068760},{"date":"2025-03-07","current":13.286691,"twenty":10.205978,"median":16.606641,"eighty":83.881366,"marketCap":1933120546},{"date":"2025-03-14","current":12.896486,"twenty":10.247736,"median":16.469804,"eighty":83.77246,"marketCap":1876348391},{"date":"2025-03-21","current":13.755726,"twenty":10.312284,"median":16.338507,"eighty":83.504245,"marketCap":2001361823},{"date":"2025-03-28","current":13.144798,"twenty":10.376454,"median":16.238513,"eighty":83.067243,"marketCap":1912476126},{"date":"2025-04-04","current":12.206729,"twenty":10.399821,"median":16.226072,"eighty":82.226514,"marketCap":1775993572},{"date":"2025-04-11","current":11.426318,"twenty":10.407213,"median":16.187354,"eighty":81.348729,"marketCap":1662449262},{"date":"2025-04-17","current":11.012464,"twenty":10.415263,"median":16.145497,"eighty":81.272408,"marketCap":1602236371},{"date":"2025-04-25","current":11.608051,"twenty":10.448423,"median":16.124567,"eighty":81.087665,"marketCap":1688890198},{"date":"2025-05-02","current":11.777656,"twenty":10.464105,"median":16.052479,"eighty":80.590796,"marketCap":1713566473},{"date":"2025-05-09","current":12.818281,"twenty":10.466983,"median":16.003645,"eighty":80.372982,"marketCap":1957595034},{"date":"2025-05-16","current":12.870923,"twenty":10.478517,"median":15.92458,"eighty":79.868998,"marketCap":1965634439},{"date":"2025-05-23","current":12.833321,"twenty":10.480992,"median":15.845515,"eighty":79.0395,"marketCap":1959892007},{"date":"2025-05-30","current":12.80324,"twenty":10.49053,"median":15.840864,"eighty":78.980541,"marketCap":1955298061},{"date":"2025-06-06","current":13.171733,"twenty":10.578477,"median":15.754823,"eighty":78.74184,"marketCap":2011573894},{"date":"2025-06-13","current":12.532511,"twenty":10.589477,"median":15.719942,"eighty":78.332349,"marketCap":1913952552},{"date":"2025-06-20","current":12.2129,"twenty":10.590235,"median":15.640877,"eighty":78.069551,"marketCap":1865141881},{"date":"2025-06-23","current":11.991052,"twenty":10.590425,"median":15.608321,"eighty":78.003851,"marketCap":1831261532}],"updateTime":1750772356778}}}